The Baloise and Helvetia Swiss insurance giants have obtained crucial regulatory approvals for their planned merger.
The approvals include the green light from the Swiss Competition Commission and the conclusion of the examination of the regulation of foreign grants of the European Commission (EC).
Following these approvals, the companies announced that the transaction would be classified on December 5, 2025, subject to obtaining all the remaining regulatory authorizations.
The agreement was announced for the first time in April of this year and received the approval of shareholders on May 23, 2025.
The two companies have collaborated with regulators to obtain the remaining approvals, said the joint press release.
On December 5, 2025, Baloise actions will be negotiated for the last time before being struck off.
The new actions of Helvetia Baloise should start to negotiate on December 8, 2025.
The combined entity will be named Helvetia Baloise Holding and based in Basel, maintaining a presence in St. Gallen.
The merger should position Helvetia Baloise as the second insurance group in Switzerland, with commercial volumes reaching 20 billion SFR (25.12 billion dollars), the Swiss insurers noted at the time of the announcement of the agreement.
With operations in around eight countries and a global specialized company, Helvetia Baloise will have a workforce greater than 22,000 employees.
The combined raw bonuses will amount to 8.6 billion SFR for the life sector and at 11.5 billion SFR for the non-life company.
The Board of Directors of the merged company will feature CEO Fabian Rupprecht of Helvetia and Deputy CEO and integration chief Michael Müller de Baloise.
Financial advice roles are fulfilled by JP Morgan Securities for Helvetia and Morgan Stanley International for Baloise, UBS also providing financial advice.
Walder Wyss for Helvetia and Lenz & Staehelin provided Baloise legal advice on the transaction.
“Swiss insurers Baloise and Helvetia are gaining regulatory approvals for the merger” has been created and originally published by Life Insurance International, a brand belonging to Globaldata.
Information on this site was included in good faith for general information only. It is not intended to constitute advice on which you should count, and we do not give any representation, guarantee or guarantee, whether express or implicit as to its precision or its exhaustiveness. You must obtain professional or specialized advice before taking or abstaining from any action on the basis of the content of our site.
